Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1449 | Thyroid (non-cancer) | ECE2017

The usefulness of the study of sodium iodide symporter expression in thyroid primary tumors

Tavares Catarina , Coelho Maria Joao , Eloy Catarina , Melo Miguel , da Rocha Adriana Gaspar , Pestana Ana , Batista Rui , Ferreira Luciana Bueno , Rios Elisabete , Cavadas Bruno , Pereira Luisa , Selmi-Ruby Samia , Simoes Manuel Sobrinho , Soares Paula

Thyroid cancer therapy is based on surgery followed by radioiodine treatment of tumor remnants and metastases. The incorporation of radioiodine by cancer cells is mediated by sodium iodide symporter (NIS), normally present in thyroid follicular cellsÂ’ membrane. We studied the expression of NIS in a series of 229 thyroid primary tumors using real time PCR and immunohistochemistry, and searched for possible associations between NIS expression and clinicopathological feature...

ea0073aep148 | Calcium and Bone | ECE2021

Paraplegia: a serious consequence of treatment delay in hyperparathyroidism During the COVID-19 pandemic

Lopes Sara Campos , Carvalho Renata , Marques Sofia , Rocha Sofia , Viana Charlene , Marques Helena , José Pedro Pinto , Mário Reis , Cavadas Sofia , Pereira Ricardo S. , Monteiro Ana Margarida

BackgroundCurrently, serious complications of secondary hyperparathyroidism (sHPT) are rare due to early diagnosis and more effective treatments. These complications include osteitis fibrosa cystica, which is characterized by bone resorption and brown tumors. Depending on the location, they can cause pain or compressive symptoms.Case reportWe report a case of a 41-year-old black woman with a past medical hist...